Dr Jerry Vockley, Director of the Center for Rare Disease Therapy and Chief of the Division of Genetic and Genomic Medicine at CHP, has been awarded a prestigious Rare Impact Award.

Given to a select few individuals each year by the National Organization for Rare Disorders (NORD), Rare Impact Awards recognize individuals driving progress for rare diseases.

Dr Vockley was presented the award in the Scientific and Medical Trailblazer category during the NORD Rare Disease Scientific Symposium. This event was held in Washington, D.C. from June 2-3, 2025 and gathered individuals from medicine, regulatory agencies (including the FDA and NIH), patient advocacy groups, and industry to help accelerate breakthroughs for rare disease. Dr Vockley was specifically recognized for his unwavering commitment to clinical research and care of patients with rare genetic conditions.

Please join me in congratulating Dr Vockley on this well-deserved achievement!